EMVision Medical Devices
Logotype for EMVision Medical Devices Ltd

EMVision Medical Devices (EMV) investor relations material

EMVision Medical Devices H1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for EMVision Medical Devices Ltd
H1 2026 earnings summary26 Feb, 2026

Executive summary

  • Developed portable neurodiagnostic devices for acute neurological emergencies, targeting stroke and traumatic brain injury markets with multi-billion-dollar potential and unmet needs in acute care and rural health.

  • Over $60 million invested in R&D, with strong clinical data, global partnerships, and significant grant agreements, including a $3M CRC-P grant for regional stroke care studies.

  • Six pivotal clinical studies underway, including collaborations with leading stroke centers, ambulance services, and regional partners.

  • Strong balance sheet with $17.5 million cash, $7.0 million in secured grants, and $3.8 million R&D rebate expected.

  • Loss after tax for the half-year was $3,967,663, up from $3,571,869 year-over-year, mainly due to higher non-cash share-based payment expenses.

Financial highlights

  • Net loss after tax for 1H26 was $3.97 million, compared to $3.57 million loss in 1H25, with net loss per share at 4.45 cents.

  • Total non-dilutive grant income and R&D tax incentive income reached $3.8 million for the half.

  • Cash and cash equivalents at period end were $17,545,236, up from $10,456,814 at June 2025, following a $14 million capital raise.

  • Total expenses rose to $8,014,381 (from $6,883,300), driven by R&D, employee, and share-based payment costs.

  • Net assets increased to $19,741,470 from $9,282,964 at June 2025.

Outlook and guidance

  • Targeted completion of pivotal trial enrolment and readout in 1H26, with FDA De Novo submission planned.

  • Multiple clinical studies progressing, including aeromedical, mobile stroke unit, and road ambulance studies.

  • Anticipates further grant receipts contingent on milestone achievements, including $4M from the Industry Growth Program and $2.6M from CRC-P through 2028.

  • Expects to receive a $3.8M R&D Tax Incentive rebate in Q1 2026.

  • Commercial launch focused on the US 'Stroke Belt' region, with plans for national and international expansion.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
EMVision Medical Devices
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

EMVision Medical Devices Ltd is a medical technology company focused on the development of non-invasive imaging solutions for the diagnosis and monitoring of neurological disorders. The company’s primary innovation is its portable brain scanner, designed to use electromagnetic microwave imaging technology to rapidly detect and monitor conditions such as strokes. EMVision aims to provide healthcare professionals with accurate, bedside imaging tools that can improve the speed and effectiveness of patient care, particularly in emergency settings. EMVision Medical Devices Ltd is headquartered in Sydney, Australia, and its shares are listed on the ASX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage